Home Blueberry Therapeutics

Blueberry Therapeutics

In operation
-
Developer of Nanotherapy for Skin Diseases
Basic
Enterprise Profile

Basic Information

Blueberry Therapeutics Focuses on the Research and Development of Treatments for Skin Diseases. By utilizing this new preclinical molecular technology, a foundation has been laid for the development of effective small-molecule antibodies in preclinical research. By concentrating on well-validated drug targets and ensuring our candidate molecules have very low toxicity, we believe we can mitigate or even avoid the two main causes of clinical drug failure.
Blueberry Therapeutics Ltd
United Kingdom
15~50 people
January 01, 2011
info@blueberrytherapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Concept
Dermatology Department
Application Scenarios
Chemical Drug Nanotechnology